Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
424.50    1.50 (0.35%)
Bid:
424.50
Ask:
426.00
Spread: 1.50 (0.353%)
Market Cap: £1.38b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Hardman&Co- Making a case study for outperformance

17 Mar 2023 14:45

RNS Number : 4127T
Fidelity Special Values PLC
17 March 2023
 

Hardman & Co Research on Fidelity Special Values Plc (FSV):

Making a case study for outperformance

 

With FSV having recently reached a decade of outperformance under fund manager Alex Wright's stewardship, we look at what has made this happen. We outline the investment process, and then provide a couple of detailed case studies to illustrate how it works in practice. The approach is essentially a contrarian one, using Fidelity's experienced team of analysts to look for unappreciated companies where there is a catalyst for change. This is underpinned by low valuations, which are used to provide downside protection, rather than being the source of outperformance that a conventional value approach might take.

 

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/making-a-case-study-for-outperformance/

If you are interested in meeting the company, you can register your interest by clicking on the above link.

 

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Brian Moretta+44 (0)203 693 7075

 

bm@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJRMITMTTBBIJ
Date   Source Headline
1st Apr 20262:28 pmPRNTotal Voting Rights
1st Apr 20267:51 amRNSNet Asset Value(s)
31st Mar 20267:56 amRNSNet Asset Value(s)
30th Mar 20264:43 pmPRNMonthly Factsheet
30th Mar 20267:53 amRNSNet Asset Value(s)
27th Mar 20268:12 amRNSNet Asset Value(s)
26th Mar 20267:38 amRNSNet Asset Value(s)
25th Mar 20267:37 amRNSNet Asset Value(s)
24th Mar 20267:47 amRNSNet Asset Value(s)
23rd Mar 20267:49 amRNSNet Asset Value(s)
23rd Mar 20267:00 amPRNDoc re. Compliance with Market Abuse Regulations
20th Mar 20267:54 amRNSNet Asset Value(s)
19th Mar 20267:56 amRNSNet Asset Value(s)
18th Mar 20263:16 pmPRNPortfolio Update
18th Mar 20267:49 amRNSNet Asset Value(s)
17th Mar 20267:48 amRNSNet Asset Value(s)
16th Mar 20267:43 amRNSNet Asset Value(s)
13th Mar 20267:42 amRNSNet Asset Value(s)
12th Mar 20267:35 amRNSNet Asset Value(s)
10th Mar 20267:55 amRNSNet Asset Value(s)
9th Mar 20267:38 amRNSNet Asset Value(s)
6th Mar 20267:50 amRNSNet Asset Value(s)
5th Mar 20268:00 amRNSNet Asset Value(s)
4th Mar 20268:03 amRNSNet Asset Value(s)
3rd Mar 202610:48 amPRNMonthly Factsheet
3rd Mar 20267:47 amRNSNet Asset Value(s)
2nd Mar 20264:03 pmPRNTotal Voting Rights
2nd Mar 20267:48 amRNSNet Asset Value(s)
27th Feb 20267:59 amRNSNet Asset Value(s)
26th Feb 20264:49 pmPRNIssue of Equity
26th Feb 20261:24 pmPRNIssue of Equity
26th Feb 20267:47 amRNSNet Asset Value(s)
25th Feb 20267:47 amRNSNet Asset Value(s)
24th Feb 20263:22 pmPRNIssue of Equity
24th Feb 20267:36 amRNSNet Asset Value(s)
23rd Feb 20267:40 amRNSNet Asset Value(s)
20th Feb 20267:53 amRNSNet Asset Value(s)
19th Feb 20264:26 pmPRNIssue of Equity
19th Feb 20267:54 amRNSNet Asset Value(s)
18th Feb 20268:01 amRNSNet Asset Value(s)
17th Feb 20267:48 amRNSNet Asset Value(s)
16th Feb 20267:52 amRNSNet Asset Value(s)
13th Feb 20264:17 pmPRNIssue of Ordinary Shares from Treasury
13th Feb 20267:52 amRNSNet Asset Value(s)
12th Feb 20267:43 amRNSNet Asset Value(s)
11th Feb 20267:54 amRNSNet Asset Value(s)
10th Feb 20267:50 amRNSNet Asset Value(s)
9th Feb 20264:35 pmPRNIssue of Ordinary Shares from Treasury
9th Feb 20267:35 amRNSNet Asset Value(s)
6th Feb 20264:25 pmPRNIssue of Ordinary Shares from Treasury

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.